Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma

J Cutan Med Surg. Jul-Aug 2003;7(4 Suppl):3-7. doi: 10.1007/s10227-003-5001-1.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Female
  • Humans
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / therapeutic use
  • Lymphoma, T-Cell, Cutaneous / drug therapy
  • Lymphoma, T-Cell, Cutaneous / mortality
  • Lymphoma, T-Cell, Cutaneous / therapy*
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Mycosis Fungoides / drug therapy
  • Mycosis Fungoides / therapy
  • Photopheresis* / adverse effects
  • Prospective Studies
  • Remission Induction
  • Retrospective Studies
  • Sezary Syndrome / drug therapy
  • Sezary Syndrome / therapy
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / therapy
  • Treatment Outcome

Substances

  • Immunologic Factors